SCHEMBL8198751

SCHEMBL8198751

Fc1cccc(-c2ccc3oc(-c4ccccc4C4=NCCN4)cc3c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 11/20 0.54
ALDH1A1 P00352 3/20 0.51
CYP1A2 P05177 3/20 0.51
HSD17B10 Q99714 3/20 0.51
CYP2D6 P10635 2/20 0.51
HPGD P15428 2/20 0.51
ADRA2A P08913 2/20 0.51
ADRA2B P18089 2/20 0.51
ADRA2C P18825 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
PRMT1 Q99873 2/20 0.47
PRMT3 O60678 1/20 0.47
EHMT2 Q96KQ7 1/20 0.47
PRMT6 Q96LA8 1/20 0.47
PRMT8 Q9NR22 1/20 0.47
USP2 O75604 1/20 0.44
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8194569 0.90 NISCH (0.56) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL6824770 0.90 NISCH (0.60) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
Hydrochloric Acid SCHEMBL7735548 0.89 NISCH (0.59) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8201878 0.87 NISCH (0.51) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8202555 0.86 NISCH (0.48) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8198114 0.85 NISCH (0.54) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8200670 0.84 NISCH (0.53) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8196630 0.84 NISCH (0.53) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8188097 0.84 NISCH (0.57) NISCHALDH1A1CYP1A2HSD17B10CYP2D6
SCHEMBL8206599 0.83 NISCH (0.55) NISCHALDH1A1CYP1A2HSD17B10CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed